Stay updated on Phase 2a Safety of MEDI8852 in Influenza Clinical Trial
Sign up to get notified when there's something new on the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page.

Latest updates to the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” terminology is no longer displayed. The page continues to show a 403 Forbidden error.SummaryDifference1%

- Check15 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA notice announces an NIH transition update, including a statement that federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with links to updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe footer site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record, indicating access to the record is blocked at this time.SummaryDifference18%

Stay in the know with updates to Phase 2a Safety of MEDI8852 in Influenza Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page.